Large vessel vasculitis is a group of rare autoimmune diseases that cause inflammation in the walls of the body’s largest arteries. The two main types are giant cell arteritis and Takayasu arteritis. Symptoms often include headaches, jaw pain, vision changes, and arm or leg pain with activity. Treatment typically involves high-dose corticosteroids to quickly control inflammation, followed by longer-term immunosuppressive medications to prevent relapses and damage.
What Is Large Vessel Vasculitis?
Vasculitis means inflammation of the blood vessels. In large vessel vasculitis, the inflammation targets the aorta and its major branches. These are the largest arteries in the body, including the carotid arteries in the neck and the subclavian arteries near the collarbone.
When these arteries become inflamed, the vessel walls thicken. Blood flow through them can slow down or stop entirely. This reduces oxygen delivery to the organs and tissues those arteries feed. Over time, the vessel wall can weaken and bulge, forming an aneurysm. It can also scar and narrow permanently.
The two main forms of large vessel vasculitis are distinct diseases. Giant cell arteritis almost always affects people over 50, with the average age of diagnosis around 70. Takayasu arteritis typically begins in women under 40, often in their 20s or 30s. Both are chronic conditions that require long-term medical care.
What Are the Symptoms of Large Vessel Vasculitis?
Symptoms depend on which arteries are inflamed and how severely. Some people have vague symptoms for months before diagnosis. Others develop sudden, dramatic symptoms.
Common symptoms of giant cell arteritis include:
- New, persistent headache, often at the temples
- Tenderness when touching the scalp
- Jaw pain when chewing that stops when chewing stops
- Vision changes, including sudden vision loss in one eye
- Fever, weight loss, and fatigue
- Stiffness and pain in the shoulders, neck, and hips, which may indicate a related condition called polymyalgia rheumatica
Takayasu arteritis presents differently. Early symptoms are often nonspecific, like low-grade fever, night sweats, and joint pain. As the disease progresses, reduced blood flow causes more specific problems:
- Arm or leg pain with activity that improves with rest
- A difference in blood pressure between the left and right arm
- Weak or absent pulses in the arms
- Dizziness or fainting episodes
- Shortness of breath or chest pain
Vision loss is a medical emergency in giant cell arteritis. It can be permanent if not treated immediately. Anyone with sudden vision changes plus a headache or jaw pain should go to an emergency room without delay.
How Is Large Vessel Vasculitis Diagnosed?
No single test confirms large vessel vasculitis. Doctors combine physical examination, blood tests, and imaging to make the diagnosis.
Blood tests typically show elevated markers of inflammation. The two most commonly measured are erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). These tests are sensitive but not specific. Many other conditions raise these markers, including infections and other autoimmune diseases. A normal ESR does not completely rule out giant cell arteritis, though it makes it less likely.
Imaging has become the standard for confirming the diagnosis. Ultrasound can show thickening of the temporal artery wall in giant cell arteritis. Magnetic resonance angiography (MRA) and computed tomography angiography (CTA) can reveal narrowing or thickening of the aorta and its branches in both diseases. Positron emission tomography (PET) scans can highlight areas of active inflammation throughout the large arteries.
In giant cell arteritis, a temporal artery biopsy has historically been the gold standard. A small piece of the artery is removed and examined under a microscope. However, the inflammation can skip sections of the artery, so a negative biopsy does not rule out the disease. Many specialists now treat based on imaging findings and clinical symptoms rather than requiring a biopsy.
What Is the Treatment for Large Vessel Vasculitis?
Treatment begins immediately after diagnosis or even when the diagnosis is strongly suspected. The goal is to stop inflammation quickly, prevent tissue damage, and then maintain control with the lowest possible medication doses.
Corticosteroids are the first-line treatment. Prednisone is usually started at a high dose, often 40 to 60 milligrams per day for giant cell arteritis. Takayasu arteritis may require similar doses. The dose is gradually tapered over many months as symptoms improve and inflammatory markers normalize. Some patients need low-dose steroids for years.
Because high-dose steroids carry significant side effects, doctors add other medications to reduce steroid exposure. Tocilizumab, an injectable biologic, is approved for giant cell arteritis. It targets a specific inflammatory protein called interleukin-6. Research has shown it helps patients achieve remission faster and with less steroid use.
Methotrexate is an oral immunosuppressant sometimes used in both conditions. It helps some patients reduce their steroid dose. Other immunosuppressants like azathioprine or mycophenolate may be used in Takayasu arteritis, though evidence supporting them is less robust.
Aspirin in low doses is often recommended to reduce the risk of blood clots and stroke, particularly in giant cell arteritis. This is based on the understanding that inflamed arteries are more prone to clotting, though the evidence for aspirin specifically in this disease is limited.
Surgery is occasionally needed for complications. If a vessel has narrowed dangerously or an aneurysm has formed, a bypass graft or stent may be placed. Surgery does not cure the disease. It only repairs the damage. Inflammation must still be controlled with medication.
What Happens Without Treatment?
Untreated large vessel vasculitis is a progressive disease. In giant cell arteritis, the most feared complication is permanent vision loss. This occurs when inflammation blocks the artery that supplies the optic nerve. Blindness can develop within days or even hours of symptom onset.
Untreated Takayasu arteritis leads to progressive narrowing of major arteries. This can cause stroke, kidney failure from blocked renal arteries, heart attack, or aortic aneurysm rupture. These complications are serious and can be fatal.
With treatment, the outlook improves substantially. Most patients with giant cell arteritis achieve remission, though relapses are common and require careful monitoring. Takayasu arteritis follows a more variable course. Some patients have long periods of quiet disease, while others experience frequent flares despite treatment.
What Are the Long-Term Risks of Treatment?
Treatment itself carries risks, primarily from long-term corticosteroid use. These risks are well documented and include:
- Weight gain and fluid retention
- High blood pressure and diabetes
- Thinning bones, leading to osteoporosis and fractures
- Cataracts and glaucoma
- Increased risk of infections
Patients on long-term steroids should have regular bone density testing and monitoring of blood pressure and blood sugar. Calcium and vitamin D supplements are often recommended to protect bone health. Doctors aim to taper steroids to the lowest effective dose as quickly as safely possible.
Immunosuppressive medications also raise infection risk. Patients should report fevers or signs of infection promptly. Live vaccines should generally be avoided while on significant immunosuppression, so vaccine timing should be discussed with a rheumatologist.
Can Large Vessel Vasculitis Be Cured?
There is no cure for large vessel vasculitis. It is a chronic disease, meaning it requires ongoing management. The word remission is more accurate than cure. Remission means the disease is inactive, with no symptoms and normal inflammatory markers, while the patient is on treatment or after treatment has been stopped.
Many patients achieve remission. Some can eventually stop all medications, though relapse is always possible. Others need continuous low-dose therapy to stay well. The disease course varies significantly from person to person, and no reliable way exists to predict who will do well and who will relapse.
Regular follow-up with a rheumatologist is essential. Monitoring includes periodic imaging to check for new vessel narrowing or aneurysm formation. Blood tests track inflammation. Blood pressure is checked in both arms at every visit. These checks catch silent disease activity before it causes irreversible damage.
Frequently Asked Questions
Is large vessel vasculitis the same as giant cell arteritis?
Giant cell arteritis is one type of large vessel vasculitis, but not the only one. Takayasu arteritis is the other major type. They differ by age of onset, affected populations, and some clinical features, but both involve inflammation of the largest arteries.
Can large vessel vasculitis cause a stroke?
Yes, it can. Inflammation of the carotid or vertebral arteries can reduce blood flow to the brain or cause clots to form. Stroke is a recognized complication of both giant cell arteritis and Takayasu arteritis, which is why prompt treatment matters.
How fast does giant cell arteritis cause blindness?
Vision loss can occur suddenly and can become permanent within hours to days of onset. This is why sudden vision changes with headache or jaw pain are treated as an emergency. Immediate high-dose steroids can often prevent blindness even when the diagnosis is not yet confirmed.
What is the life expectancy with Takayasu arteritis?
Most people with Takayasu arteritis live a normal lifespan with proper treatment. Complications like aneurysm rupture or stroke can shorten life, but these are less common when the disease is well controlled. Regular monitoring for vessel damage is a key part of long-term care.
